SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Labrador who wrote (211)4/11/1998 9:59:00 PM
From: Haolin Ni  Read Replies (2) of 712
 
Yes, I agree with you. The FDA Committee Recommends Approval of Merck's Platelet Blocker Aggrastat(R) for the Treatment of Unstable Angina is not a good news for CORR. Remember that FDA Committee did not recommend approval INTEGRILIN of CORR to be used for unstable angina few months back.

The production and market abilities of MRK, LLY and CNTO are far better than CORR so that CORR will not get big part of the pie.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News